18 results on '"Velasquez, M. Paulina"'
Search Results
2. Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells
3. Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificity
4. Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
5. GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells
6. Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia
7. Engineering naturally occurring CD7− T cells for the immunotherapy of hematological malignancies
8. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
9. CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells
10. Allogeneic CD7-CAR T cells to bridge the gap?
11. Leukemia's Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy.
12. A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy.
13. Erythrocytapheresis in children with sickle cell disease and acute chest syndrome.
14. Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?
15. Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulation.
16. Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages.
17. CD7 CAR: sword and shield.
18. Employing Synthetic T-cell Biology to Target AML without On-Target/Off-Cancer Toxicity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.